Related Experiment Video
Updated: Jun 18, 2026

Measuring Cell-Edge Protrusion Dynamics during Spreading using Live-Cell Microscopy
Published on: November 1, 2021
Differential requirement for MEK Partner 1 in DU145 prostate cancer cell migration
Electa R Park1, Ashok K Pullikuth, Evangeline M Bailey
1Department of Pharmacology, LSU Health Sciences Center-New Orleans, LA, USA. acatli@lsuhsc.edu.
Abstract:
ERK signaling regulates focal adhesion disassembly during cell movement, and increased ERK signaling frequently contributes to enhanced motility of human tumor cells. We previously found that the ERK scaffold MEK Partner 1 (MP1) is required for focal adhesion disassembly in fibroblasts. Here we test the hypothesis that MP1-dependent ERK signaling regulates motility of DU145 prostate cancer cells. We find that MP1 is required for motility on fibronectin, but not for motility stimulated by serum or EGF. Surprisingly, MP1 appears not to function through its known binding partners MEK1 or PAK1, suggesting the existence of a novel pathway by which MP1 can regulate motility on fibronectin. MP1 may function by regulating the stability or expression of paxillin, a key regulator of motility.
Insights
MEK Partner 1 (MP1) is crucial for prostate cancer cell motility on fibronectin, independent of its known partners. This suggests a novel pathway regulating cell movement and potentially impacting cancer progression.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Signaling
Background:
- Extracellular signal-regulated kinase (ERK) signaling is vital for focal adhesion disassembly and cell motility.
- Enhanced ERK signaling is often linked to increased human tumor cell motility.
- MEK Partner 1 (MP1) acts as an ERK scaffold and is essential for focal adhesion disassembly in fibroblasts.
Purpose of the Study:
- To investigate the role of MP1-dependent ERK signaling in the motility of DU145 prostate cancer cells.
- To determine if MP1 regulates prostate cancer cell migration on specific extracellular matrix components.
Main Methods:
- Utilized DU145 prostate cancer cell lines.
- Assessed cell motility on fibronectin, serum, and epidermal growth factor (EGF).
- Investigated the involvement of MP1 and its known binding partners (MEK1, PAK1).
Main Results:
- MP1 is essential for DU145 cell motility on fibronectin.
- MP1's role in motility on fibronectin is independent of MEK1 and PAK1.
- MP1 may regulate motility by affecting paxillin stability or expression.
Conclusions:
- MP1 plays a critical role in prostate cancer cell motility on fibronectin through a novel pathway.
- This pathway does not involve MP1's canonical binding partners MEK1 or PAK1.
- MP1's regulation of paxillin presents a potential therapeutic target for inhibiting prostate cancer metastasis.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Chemotaxis and Direction of Cell Migration
MAPK Signaling Cascades
Cell Polarization by Rho Proteins
